Scarica l'app Stockscreener
3.85
4.90%
0.18
Pre-mercato:
3.97
0.12
+3.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$3.67
Aprire:
$3.71
Volume 24 ore:
5.23M
Relative Volume:
1.02
Capitalizzazione di mercato:
$921.15M
Reddito:
$251.85M
Utile/perdita netta:
$-72.58M
Rapporto P/E:
-12.28
EPS:
-0.3134
Flusso di cassa netto:
$-63.80M
1 W Prestazione:
-3.02%
1M Prestazione:
-6.78%
6M Prestazione:
-30.51%
1 anno Prestazione:
-43.88%
Intervallo 1D:
$3.5701
$3.93
Intervallo di 1 settimana:
$3.5701
$4.06
Portata 52W:
$3.21
$8.06
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.85 | 949.84M | 251.85M | -72.58M | -63.80M | -0.3134 |
|
ONC
Beone Medicines Ltd Adr
|
245.93 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.415 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.10 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.81 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx appoints Mike Kelliher Chief Business Officer - TipRanks
Ardelyx Promotes Mike Kelliher to Chief Business Officer - marketscreener.com
Ardelyx (ARDX) Appoints New Leadership in Strategic Roles | ARDX Stock News - GuruFocus
Ardelyx reshuffles leadership, adds new HR chief By Investing.com - Investing.com Canada
Ardelyx Appoints Mike Kelliher Chief Business Officer - marketscreener.com
Ardelyx Appoints Mike Kelliher Chief Business Officer and James - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer - TradingView
Ardelyx Expands Leadership: Strategic Promotion and Key Executive Hire Signal Growth Push - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc.ARDX - WV News
Ardelyx, Inc. (ARDX) Stock Analysis: Investors Eye a Promising 167.99% Upside Potential - DirectorsTalk Interviews
Learn to Evaluate (ARDX) using the Charts - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
2 ‘Strong Buy’ Small-Cap Stocks With Blockbuster Potential - The Globe and Mail
Deutsche Bank AG Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Ardelyx chief medical officer sells shares worth $26,206 By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock By Investing.com - Investing.com South Africa
Ardelyx chief medical officer sells shares worth $26,206 - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock - Investing.com Australia
Ardelyx Executives Sell Shares to Cover Taxes - TradingView
Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 | ARDX Stock News - GuruFocus
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 - The Manila Times
Ardelyx CEO Mike Raab to Share Company Vision at Major Healthcare Conference 2025 - Stock Titan
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ardelyx, Inc.(ARDX) Shareholders - ACCESS Newswire
BNP Paribas Financial Markets Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Director David Mott Acquires 100,000 Shares of Ardelyx Inc (ARDX) - GuruFocus
Ardelyx falls 14% as Q1 results miss on both lines - MSN
Northern Trust Corp Purchases 50,441 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
The Manufacturers Life Insurance Company Sells 130,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Benign Growth For Ardelyx, Inc. (NASDAQ:ARDX) Underpins Stock's 28% Plummet - simplywall.st
Investors Who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
Investors who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
I Have a Prescription for These Two Biopharmas That Fell After Earnings - TheStreet Pro
Cantor Fitzgerald Forecasts Reduced Earnings for Ardelyx - Defense World
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Ardelyx, Inc. (ARDX) - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire
Ardelyx, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Ardelyx, Inc. (ARDX) - ACCESS Newswire
David Mott Bought 19% More Shares In Ardelyx - simplywall.st
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Ardelyx, Inc. Class Action: Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Ardelyx, Inc.(ARDX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – ARDX - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationARDX - ACCESS Newswire
Investors who lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):